@article{cada25b485dd42adaa9e9f0cc5c5b6b8,
title = "Aggressive Acquired Demyelinating Neuropathy Caused by NF-155: Initially Treatment-Resistant",
keywords = "CIDP, COVID, Medical Research Council, NF-155, cerebrospinal fluid, chronic inflammatory demyelinating polyradiculoneuropathy, coronavirus disease, electromyography, nodal or paranodal proteins, treatment resistance, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/complications, Humans, Immunoglobulin G, Rituximab, Male, Immunoglobulins, Intravenous/therapeutic use, Adult, Steroids",
author = "Selene Jamall and Nancy Baker and Gordon Peterson and Bryan Tsao and Jeffrey Rosenfeld",
note = "Publisher Copyright: {\textcopyright} 2023 Lippincott Williams and Wilkins. All rights reserved.",
year = "2023",
month = dec,
day = "1",
doi = "10.1097/CND.0000000000000464",
language = "English",
volume = "25",
pages = "59--62",
journal = "Journal of Clinical Neuromuscular Disease",
issn = "1522-0443",
number = "2",
}